The impact of thrombin generation and rotation thromboelastometry on assessment of severity of factor XI deficiency

Thrombosis Research

Volumn 136, Issue 2, 2015, Pages 465-473

  Livnat, Tami ^a   Shenkman, Boris ^a   Martinowitz, Uri ^a   Zivelin, Ariella ^b   Dardik, Rima ^a   Tamarin, Ilia ^b   Mansharov, Rachel ^b   Budnik, Ivan ^c   Salomon, Ophira ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

factor XI deficiency; thrombin generation; thromboelastometry

Indexed keywords

THROMBIN; THROMBOPLASTIN; TRYPSIN INHIBITOR; BLOOD CLOTTING FACTOR 11;

ARTICLE; BLEEDING TENDENCY; BLOOD; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; ROTATION THROMBOELASTOMETRY; THROMBOCYTE POOR PLASMA; THROMBOELASTOGRAPHY; COMPLICATION; DIFFERENTIAL DIAGNOSIS; FACTOR XI DEFICIENCY; HEMORRHAGE; PROCEDURES; PROGNOSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

DIAGNOSIS, DIFFERENTIAL; FACTOR XI; FACTOR XI DEFICIENCY; HEMORRHAGE; HUMANS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; THROMBELASTOGRAPHY; THROMBIN;

EID: 84938548529     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.06.025     Document Type: Article

References (26)

1. A. Matafonov, Q. Cheng, Y. Geng, I.M. Verhamme, O. Umunakwe, E.I. Tucker, and et al. Evidence for factor IX-independent roles for factor XIa in blood coagulation J. Thromb. Haemost. 11 2013 2118 2127
2. M.F. Whelihan, T. Orfeo, M.T. Gissel, and K.G. Mann Coagulation procofactor activation by factor XIa J. Thromb. Haemost. 8 2010 1532 1539
3. C. Puy, E.I. Tucker, A. Matafonov, Q. Cheng, F.D. Zientek, D. Gailabi, and et al. Activated factor XI increases the procoagulant activity of the extrinsic pathway by inactivating tissue factor pathway inhibitor Blood 125 2015 1488 1496
4. S. Duga, and O. Salomon Congenital factor XI deficiency: An update Semin. Thromb. Hemost. 39 2013 621 631
5. O. Salomon, D.M. Steinberg, and U. Seligshon Variable bleeding manifestations characterize different types of surgery in patients with severe factor XI deficiency enabling parsimonious use of replacement therapy Haemophilia 12 2006 490 493
6. M. Zucker, O. Salomon, U. Seligsohn, and A.S. Wolberg Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency J. Thromb. Haemost. 12 2014 1121 1130
7. H. Schöchl, U. Nienaber, G. Hofer, W. Voelcker, C. Jambor, G. Scharbert, and et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate Crit. Care 14 2010 R55
8. G. Young, B. Sørensen, Y. Dargaud, C. Negrier, K. Brummel-Ziedins, and N.S. Key Thrombin generation and whole blood viscoelastic assays in the management of hemophilia: Current state of art and future perspectives Blood 121 2013 1944 1950
9. N.M. O'Connell, A.F. Riddell, G. Pascoe, G. Pascoe, D.J. Perry, and C.A. Lee Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency Haemophilia 14 2008 775 781
10. T. Livnat, I. Tamarin, Y. Mor, H. Winckler, Z. Horowitz, Y. Korianski, and et al. Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies Thromb. Haemost. 102 2009 487 492
11. A. Riddell, R. Abdul-Kadir, D. Pollard, E. Tuddenham, and K. Gomez Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery Thromb. Haemost. 106 2011 521 527
12. L. Rugeri, F. Quélin, B. Chatard, P. De Mazancourt, C. Neglier, and Y. Dargaud Thrombin generation in patients with factor XI deficiency and clinical bleeding risk Haemophilia 16 2010 771 777
13. R. Al Dieri, F. Peyvandi, E. Santagostino, M. Giansily, P.M. Mannucci, J.F. Schved, and et al. The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding Thromb. Haemost. 88 2002 576 582
14. D. Dirkmann, A.A. Hanke, K. Gorlinger, and J. Peters Perioperative use of modified thromboelastography in factor XI deficiency: A helpful method to assess drug effects Acta Anaesthesiol. Scand. 51 2007 640 643
15. O. Salomon, D.M. Steinberg, M. Zucker, D. Varon, A. Zivelin, and U. Seligsohn Patients with severe factor XI deficiency have a reduced incidence of deep vein thrombosis Thromb. Haemost. 105 2011 269 273
16. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, R. Wagenvoord, and et al. Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol. Haemost. Thromb. 33 2003 4 15
17. H.R. Büller, C. Bethune, S. Bhanot, D. Gailani, B.P. Monia, G.E. Raskob, and et al. Factor XI antisense oligonucleotide for prevention of venous thrombosis N. Engl. J. Med. 372 2015 232 240
18. T. Livnat, A. Zivelin, U. Martinowitz, O. Salomon, and U. Seligsohn Prerequisites for recombinant factor VIIa induced thrombin generation in plasmas deficient in factor VIII, IX or XI J. Thromb. Haemost. 4 2006 192 200
19. P. Guéguen, H. Galinat, M.T. Blouch, F. Bridey, J. Duchemin, G. Le Gal, and et al. Biological determinants of bleeding in patients with heterozygous factor XI deficiency Br. J. Haematol. 156 2012 245 251
20. I.M.L.W. Keularts, A. Zivelin, U. Seligsohn, H.C. Hemker, and S. Béguin The role of factor XI in thrombin generation induced by low concentrations of tissue factor Thromb. Haemost. 85 2001 1060 1065
21. T. Livnat, U. Martinowitz, A. Zivelin, D. Rima, and G. Kenet A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor Thromb. Haemost. 105 2011 688 695
22. D. Gailiani Future prospects for contact factors as therapeutic targets Hematology Am. Soc. Hematol. Educ. Program 2014 52 59
23. G.N. Pike, A.M. Cumming, C.R. Hay, J. Thachil, J. Burthem, and P.H. Bolton-Maggs Contact activation inhibition and platelet rich plasma are required in order to differentiate bleeders from non-bleeders in FXI deficiency using the thrombin generation assay ASH 2014 696
24. K.M. Hansson, S. Nielsen, M. Elg, and J. Deinum The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood J. Thromb. Haemost. 12 2014 1678 1686
25. S. Butenas, and K.G. Mann The effect of corn trypsin inhibitor and inhibiting antibodies for FXIa and FXIIa on coagulation of plasma and whole blood: comment J. Thromb. Haemost. 2015 487 488
26. S. Setty, A. Reddell, A. England, K. Gomez, and R. Kadir The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency Haemophilia 17 2011 906 909